🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

David Hoang

Stock Analyst at Deutsche Bank

(4.72)
# 760
Out of 5,184 analysts
130
Total ratings
53.3%
Success rate
25.3%
Average return

Stocks Rated by David Hoang

Sarepta Therapeutics
Nov 10, 2026
Upgraded: Hold
Price Target: $14 → $18
Current: $13.33
Upside: +35.03%
Axsome Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: $267 → $245
Current: $129.36
Upside: +89.39%
Neurocrine Biosciences
Nov 3, 2026
Reiterated: Hold
Price Target: $165 → $175
Current: $150.57
Upside: +16.23%
Climb Bio
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $9.19
Upside: +204.68%
Harmony Biosciences Holdings
Oct 1, 2026
Reiterated: Hold
Price Target: $39 → $42
Current: $32.59
Upside: +28.87%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $38 → $31
Current: $17.11
Upside: +81.18%
Xenon Pharmaceuticals
Sep 18, 2026
Downgraded: Hold
Price Target: $90 → $46
Current: $37.04
Upside: +24.19%
Rhythm Pharmaceuticals
Aug 27, 2026
Initiated Coverage: Hold
Price Target: $120
Current: $112.36
Upside: +6.80%
Jazz Pharmaceuticals
Aug 26, 2026
Reiterated: Buy
Price Target: $287 → $300
Current: $230.26
Upside: +30.29%
Spyre Therapeutics
Aug 26, 2026
Reiterated: Buy
Price Target: $135 → $127
Current: $93.47
Upside: +35.87%
Initiated Coverage: Hold
Price Target: $120
Current: $115.31
Upside: +4.07%
Rated: Buy
Price Target: $31 → $35
Current: $18.45
Upside: +89.70%
Rated: Buy
Price Target: $65 → $20
Current: $12.39
Upside: +61.42%
Reiterated: Buy
Price Target: $420 → $374
Current: $300.43
Upside: +24.49%
Reiterated: Buy
Price Target: $52 → $45
Current: $44.94
Upside: n/a
Initiated Coverage: Buy
Price Target: $7
Current: $0.1865
Upside: n/a
Reiterated: Buy
Price Target: $16
Current: $6.25
Upside: n/a
Reiterated: Buy
Price Target: $16
Current: $1.53
Upside: n/a
Initiated Coverage: Hold
Price Target: $220
Current: $143.82
Upside: n/a
Initiated Coverage: Buy
Price Target: $80
Current: $41.37
Upside: n/a
Downgraded: Hold
Price Target: $24 → $3
Current: $10.72
Upside: n/a
Reiterated: Buy
Price Target: $19
Current: $0.281
Upside: n/a
Initiated Coverage: Buy
Price Target: $73
Current: $308.89
Upside: n/a